The tumor suppressor protein DLC1 is regulated by PKD-mediated GAP domain phosphorylation

Exp Cell Res. 2011 Feb 15;317(4):496-503. doi: 10.1016/j.yexcr.2010.11.003. Epub 2010 Nov 16.

Abstract

Deleted in liver cancer 1 (DLC1) is a tumor suppressor protein that is frequently downregulated in various tumor types. DLC1 contains a Rho GTPase activating protein (GAP) domain that appears to be required for its tumor suppressive functions. Little is known about the molecular mechanisms that regulate DLC1. By mass spectrometry we have mapped a novel phosphorylation site within the DLC1 GAP domain on serine 807. Using a phospho-S807-specific antibody, our results identify protein kinase D (PKD) to phosphorylate this site in DLC1 in intact cells. Although phosphorylation on serine 807 did not directly impact on in vitro GAP activity, a DLC1 serine-to-alanine exchange mutant inhibited colony formation more potently than the wild type protein. Our results thus show that PKD-mediated phosphorylation of DLC1 on serine 807 negatively regulates DLC1 cellular function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Cell Line, Tumor
  • Down-Regulation
  • Female
  • GTPase-Activating Proteins / metabolism*
  • GTPase-Activating Proteins / physiology*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mass Spectrometry
  • Phosphorylation
  • Protein Interaction Domains and Motifs / physiology*
  • Protein Kinase C / physiology*
  • Tumor Suppressor Proteins / metabolism*

Substances

  • DLC1 protein, human
  • GTPase-Activating Proteins
  • Tumor Suppressor Proteins
  • rho GTPase-activating protein
  • protein kinase D
  • Protein Kinase C